Form 4: Option Care Health Director John Arlotta Receives Restricted Stock Units

Director John Arlotta of Option Care Health, Inc. was granted 9,150 restricted stock units on May 15, 2024, valued at $275,000.

Summary

• On May 15, 2024, John Arlotta, a director of Option Care Health, Inc., received 9,150 restricted stock units.
• These units were granted as compensation and vest in equal installments over three years.
• The grant was calculated to reflect a value of $275,000 based on the closing price of OPCH common stock on the grant date.
• Following this transaction, Mr. Arlotta indirectly owns 71,009 shares of common stock through the John J. Arlotta Living Trust.

Sentiment

Score: 7

Explanation: The document reflects a routine equity compensation grant, which is generally viewed neutrally to positively as it aligns director interests with shareholders. There are no indications of negative news or concerns.

Positives

• The grant of restricted stock units aligns Mr. Arlotta's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the director.

Industry Context

Equity compensation is a common practice for aligning the interests of company directors with those of shareholders. Restricted stock units are frequently used as a component of this compensation.

Comparison to Industry Standards

• Equity compensation for board members varies widely based on company size, industry, and individual contributions.
• Comparing Option Care Health's director compensation to peers like CVS Health, Walgreens Boots Alliance, and UnitedHealth Group would provide a benchmark.
• Typical director compensation packages include a mix of cash retainers, equity grants, and committee fees.

Stakeholder Impact

• The grant of restricted stock units to a director can positively influence shareholder confidence by aligning management's interests with long-term company performance.
• Employees may view this as a positive sign of the company's commitment to its leadership.

Key Dates